LM Economic Consortium
  • Certified Programs
  • For Employers
  • For Healthcare Providers
Menu
  • About
  •    The Why of the
       LMERC
  •    Who
  •    Advisory Board
  •    Staff
  • Benefits
  •    For Employers
  •    For Healthcare
       Providers
  •    For Individuals
  • Resources
    • Key Papers and Presentations
    • Certified Programs
Consulting Evidence Database Download Database
Home » Evidences » Modeling Cost Savings » Estimating health benefits and cost-savings for achieving the Healthy People 2020 objective of reducing invasive colorectal cancer.

Estimating health benefits and cost-savings for achieving the Healthy People 2020 objective of reducing invasive colorectal cancer.

Submitted by admin on Tue, 08/21/2018 - 17:39

Author(s):

Hung, M. C., et al.

Year Published:

2018

Journal:

Preventive Medicine

Categories:

Modeling Cost Savings , Other conditions

Link to Abstract Summary:

https://www.ncbi.nlm.nih.gov/pubmed/28964854

Link to Full Article Free Online:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874792/

Abstract:

This study aims to quantify the aggregate potential life-years (LYs) saved and healthcare cost-savings if the Healthy People 2020 objective were met to reduce invasive colorectal cancer (CRC) incidence by 15%. We identified patients (n=886,380) diagnosed with invasive CRC between 2001 and 2011 from a nationally representative cancer dataset. We stratified these patients by sex, race/ethnicity, and age. Using these data and data from the 2001-2011 U.S. life tables, we estimated a survival function for each CRC group and the corresponding reference group and computed per-person LYs saved. We estimated per-person annual healthcare cost-savings using the 2008-2012 Medical Expenditure Panel Survey. We calculated aggregate LYs saved and cost-savings by multiplying the reduced number of CRC patients by the per-person LYs saved and lifetime healthcare cost-savings, respectively. We estimated an aggregate of 84,569 and 64,924 LYs saved for men and women, respectively, accounting for healthcare cost-savings of $329.3 and $294.2 million (in 2013$), respectively. Per person, we estimated 6.3 potential LYs saved related to those who developed CRC for both men and women, and healthcare cost-savings of $24,000 for men and $28,000 for women. Non-Hispanic whites and those aged 60-64 had the highest aggregate potential LYs saved and cost-savings. Achieving the HP2020 objective of reducing invasive CRC incidence by 15% by year 2020 would potentially save nearly 150,000 life-years and $624 million on healthcare costs.

Need the password to download the full database of studies?

Join our mailing list to get access to this as well as other key resources demonstrating the financial benefits of lifestyle medicine and health improvements:

Employers/Professionals Click Here

Healthcare Providers Click Here

Search and Filter

Press crtl for multiple selections
Range Between Start Year and End Year

We can help to reverse the trend, with the savings going right to your bottom line.

The solvency of our nation is at stake.

Benefits Evidence Database Consulting Resources Contact

Lifestyle Medicine Economic Research Council

The LMERC is a special project of the American College of Lifestyle Medicine, a 501(c)3 non-profit charitable organization dedicated to advancing the field of lifestyle medicine as the foundation of a transformed and sustainable system of healthcare delivery.

facebook Twitter Contact
LM Economic Consortium
© 2022 American College of Lifestyle Medicine. Site By Fusion Media Marketing